Literature DB >> 33127642

Neuroligin-2 dependent conformational activation of collybistin reconstituted in supported hybrid membranes.

Jonas Schäfer1, Lucas Förster1, Ingo Mey1, Theofilos Papadopoulos2, Nils Brose3, Claudia Steinem4.   

Abstract

The assembly of the postsynaptic transmitter sensing machinery at inhibitory nerve cell synapses requires the intimate interplay between cell adhesion proteins, scaffold and adaptor proteins, and γ-aminobutyric acid (GABA) or glycine receptors. We developed an in vitro membrane system to reconstitute this process, to identify the essential protein components, and to define their mechanism of action, with a specific focus on the mechanism by which the cytosolic C terminus of the synaptic cell adhesion protein Neuroligin-2 alters the conformation of the adaptor protein Collybistin-2 and thereby controls Collybistin-2-interactions with phosphoinositides (PtdInsPs) in the plasma membrane. Supported hybrid membranes doped with different PtdInsPs and 1,2-dioleoyl-sn-glycero-3-{[N-(5-amino-1-carboxypentyl)iminodiacetic acid]succinyl} nickel salt (DGS-NTA(Ni)) to allow for the specific adsorption of the His6-tagged intracellular domain of Neuroligin-2 (His-cytNL2) were prepared on hydrophobically functionalized silicon dioxide substrates via vesicle spreading. Two different collybistin variants, the WT protein (CB2SH3) and a mutant that adopts an intrinsically 'open' and activated conformation (CB2SH3/W24A-E262A), were bound to supported membranes in the absence or presence of His-cytNL2. The corresponding binding data, obtained by reflectometric interference spectroscopy, show that the interaction of the C terminus of Neuroligin-2 with Collybistin-2 induces a conformational change in Collybistin-2 that promotes its interaction with distinct membrane PtdInsPs.
© 2020 Schäfer et al.

Entities:  

Keywords:  ); GABA receptor; GABAA receptor organization; conformational change; inhibitory postsynapse; membrane; phosphatidylinositol; phosphoinositides; reflectometric interference spectroscopy (RIfS; supported hybrid membranes (SHMs; synapse

Mesh:

Substances:

Year:  2020        PMID: 33127642      PMCID: PMC7939476          DOI: 10.1074/jbc.RA120.015347

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model.

Authors:  M Kneussel; H Betz
Journal:  Trends Neurosci       Date:  2000-09       Impact factor: 13.837

2.  Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression.

Authors:  Natalia Mitin; Laurie Betts; Marielle E Yohe; Channing J Der; John Sondek; Kent L Rossman
Journal:  Nat Struct Mol Biol       Date:  2007-08-19       Impact factor: 15.369

3.  A method improving the accuracy of fluorescence recovery after photobleaching analysis.

Authors:  Peter Jönsson; Magnus P Jonsson; Jonas O Tegenfeldt; Fredrik Höök
Journal:  Biophys J       Date:  2008-06-20       Impact factor: 4.033

4.  Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.

Authors:  Mrinalini Hoon; Tolga Soykan; Björn Falkenburger; Matthieu Hammer; Annarita Patrizi; Karl-Friedrich Schmidt; Marco Sassoè-Pognetto; Siegrid Löwel; Tobias Moser; Holger Taschenberger; Nils Brose; Frédérique Varoqueaux
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

5.  gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.

Authors:  Qiuying Shen; Rachnanjali Lal; Beth A Luellen; John C Earnheart; Anne Milasincic Andrews; Bernhard Luscher
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

Review 6.  The role of GABA in anxiety disorders.

Authors:  R Bruce Lydiard
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

7.  Lipid binding defects and perturbed synaptogenic activity of a Collybistin R290H mutant that causes epilepsy and intellectual disability.

Authors:  Theofilos Papadopoulos; Rudolf Schemm; Helmut Grubmüller; Nils Brose
Journal:  J Biol Chem       Date:  2015-02-12       Impact factor: 5.157

8.  The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.

Authors:  Kirsten Harvey; Ian C Duguid; Melissa J Alldred; Sarah E Beatty; Hamish Ward; Nicholas H Keep; Sue E Lingenfelter; Brian R Pearce; Johan Lundgren; Michael J Owen; Trevor G Smart; Bernhard Lüscher; Mark I Rees; Robert J Harvey
Journal:  J Neurosci       Date:  2004-06-23       Impact factor: 6.167

Review 9.  Recent advances in understanding phosphoinositide signaling in the nervous system.

Authors:  Eamonn James Dickson
Journal:  F1000Res       Date:  2019-03-12

10.  Mutation p.R356Q in the Collybistin Phosphoinositide Binding Site Is Associated With Mild Intellectual Disability.

Authors:  Tzu-Ting Chiou; Philip Long; Alexandra Schumann-Gillett; Venkateswarlu Kanamarlapudi; Stefan A Haas; Kirsten Harvey; Megan L O'Mara; Angel L De Blas; Vera M Kalscheuer; Robert J Harvey
Journal:  Front Mol Neurosci       Date:  2019-03-12       Impact factor: 5.639

View more
  3 in total

Review 1.  Atg8-PE protein-based in vitro biochemical approaches to autophagy studies.

Authors:  Xue Huang; Jia Yao; Lu Liu; Yu Luo; Aimin Yang
Journal:  Autophagy       Date:  2022-01-24       Impact factor: 13.391

2.  Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit.

Authors:  Dustin J Hines; April Contreras; Betsua Garcia; Jeffrey S Barker; Austin J Boren; Christelle Moufawad El Achkar; Stephen J Moss; Rochelle M Hines
Journal:  Mol Psychiatry       Date:  2022-02-15       Impact factor: 13.437

3.  Differential modulation of collybistin conformational dynamics by the closely related GTPases Cdc42 and TC10.

Authors:  Nasir Imam; Susobhan Choudhury; Katrin G Heinze; Hermann Schindelin
Journal:  Front Synaptic Neurosci       Date:  2022-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.